Immunomodulators in the Treatment of Cutaneous Lymphoma
September 1999
in “
Journal of the European Academy of Dermatology and Venereology
”
cutaneous lymphoma immunomodulatory therapies Interferon-alpha IFN-α CTCL high-dose IL-2 mycophenolate mofetil cyclosporin A monoclonal antibodies autologous BMT fusion toxins thymopentin retinoids ECP extracorporeal photopheresis vaccination therapy DAB 389 IL-2 erythrodermic CTCL cutaneous lymphoma Interferon-alpha IFN-α CTCL IL-2 mycophenolate mofetil cyclosporin A monoclonal antibodies BMT fusion toxins thymopentin retinoids ECP extracorporeal photopheresis vaccination therapy DAB 389 IL-2 erythrodermic CTCL
Studysummary This review examines various immunomodulatory therapies for cutaneous lymphoma and notes that they are most effective in the disease's early stages.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →